Financhill
Back

CRISPR Therapeutics AG Stock Predictions

CRISPR Therapeutics AG Stock Forecast

  • Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 34.7% based on the past 9 years of stock performance.
  • CRISPR Therapeutics AG has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
  • Is CRISPR Therapeutics AG Stock Undervalued?
    The current CRISPR Therapeutics AG [CRSP] share price is $48.74. The Score for CRSP is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will CRISPR Therapeutics AG Stock Go Up Next Year?

  • Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 34.7% based on the past 9 years of stock performance.

CRISPR Therapeutics AG Stock Rating

Sell
45
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG overpriced?

  • CRISPR Therapeutics AG has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%

CRISPR Therapeutics AG Stock Price History

Is CRSP stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
crisprtx.com

52-Week Data

52-Week High:
78.48
52-Week Low:
30.04

Prediction Charts

Market Cap:
4.6B
Price in USD:
48.74
Volume:
1.7M
Beta:
2.05

Technical Analysis

SMA50:
54.64
SMA100:
58.66
SMA200:
53.53
52-Wk Change:
20.02%

Stock Predictions

  • Is CRISPR Therapeutics AG stock public?
    Yes, CRISPR Therapeutics AG is a publicly traded company.
  • What is the CRISPR Therapeutics AG stock quote today?
    The CRISPR Therapeutics AG stock price is 48.74 USD today.
  • How to buy CRISPR Therapeutics AG stock online?
    You can buy CRISPR Therapeutics AG shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-20 52.02 52.61 53.46 51.00
Jan-21 52.14 54.73 54.81 51.80
Jan-22 54.53 60.81 60.86 54.22
Jan-23 60.70 55.52 60.70 55.05
Jan-26 54.77 54.65 55.71 53.72
Jan-27 55.50 54.26 56.69 53.57
Jan-28 54.30 53.69 54.63 53.07
Jan-29 53.03 53.35 54.09 52.67
Jan-30 52.12 49.96 53.84 49.73
Feb-2 49.50 51.31 51.92 49.10
Feb-3 51.23 52.00 53.00 50.61
Feb-4 51.89 50.17 52.37 48.82
Feb-5 48.86 45.88 49.63 45.53
Feb-6 47.22 48.74 48.99 46.27

CRISPR Therapeutics AG Earnings

CRISPR Therapeutics AG Earnings Report: Per Share CRISPR Therapeutics AG Earnings Q1 Q2 Q3 and Q4 last year and next year.

CRISPR Therapeutics AG Forecast Revenue Growth

CRISPR Therapeutics AG Stock Analysis: Historical quarterly revenues per share for CRISPR Therapeutics AG and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.74 per share, and an increase next year of $0.36 per share.

* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.